OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CFTR Protein: Not Just a Chloride Channel?
L. Hanssens, Jean Duchateau, Georges Casimir
Cells (2021) Vol. 10, Iss. 11, pp. 2844-2844
Open Access | Times Cited: 76
L. Hanssens, Jean Duchateau, Georges Casimir
Cells (2021) Vol. 10, Iss. 11, pp. 2844-2844
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort
Michael B. VanElzakker, Emma M. Tillman, Lael M. Yonker, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 6, pp. 603-609
Open Access | Times Cited: 24
Michael B. VanElzakker, Emma M. Tillman, Lael M. Yonker, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 6, pp. 603-609
Open Access | Times Cited: 24
Protein interactions, calcium, phosphorylation, and cholesterol modulate CFTR cluster formation on membranes
Yimei Wan, R.D.A. Hudson, Jordyn Smith, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access | Times Cited: 1
Yimei Wan, R.D.A. Hudson, Jordyn Smith, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access | Times Cited: 1
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations
Véronique Dartois, Tracey L. Bonfield, Jim P. Boyce, et al.
Tuberculosis (2024) Vol. 147, pp. 102503-102503
Closed Access | Times Cited: 7
Véronique Dartois, Tracey L. Bonfield, Jim P. Boyce, et al.
Tuberculosis (2024) Vol. 147, pp. 102503-102503
Closed Access | Times Cited: 7
Genome editing and kidney health
Nadia Tavakolidakhrabadi, Francesco Aulicino, Carl May, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 7
Nadia Tavakolidakhrabadi, Francesco Aulicino, Carl May, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 7
Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
Anabela S. Ramalho, Mieke Boon, Marijke Proesmans, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1437-1437
Open Access | Times Cited: 27
Anabela S. Ramalho, Mieke Boon, Marijke Proesmans, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1437-1437
Open Access | Times Cited: 27
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
Marcus Mall, Gerard J. Criner, Marc Miravitlles, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 4, pp. 2201307-2201307
Open Access | Times Cited: 23
Marcus Mall, Gerard J. Criner, Marc Miravitlles, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 4, pp. 2201307-2201307
Open Access | Times Cited: 23
The Epithelial Sodium Channel—An Underestimated Drug Target
Rosa Lemmens‐Gruber, Susan Tzotzos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7775-7775
Open Access | Times Cited: 15
Rosa Lemmens‐Gruber, Susan Tzotzos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7775-7775
Open Access | Times Cited: 15
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
Ryan Marsh, Claudio Dos Santos, Liam Hanson, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 14
Ryan Marsh, Claudio Dos Santos, Liam Hanson, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 14
Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del
Heledd Jarosz-Griffiths, L. Gillgrass, L.R. Caley, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0304555-e0304555
Open Access | Times Cited: 4
Heledd Jarosz-Griffiths, L. Gillgrass, L.R. Caley, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0304555-e0304555
Open Access | Times Cited: 4
The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic Fibrosis
Marta Solís García, Claudia Janeth Madrid-Carbajal, Adrián Peláez, et al.
Research Square (Research Square) (2025)
Closed Access
Marta Solís García, Claudia Janeth Madrid-Carbajal, Adrián Peláez, et al.
Research Square (Research Square) (2025)
Closed Access
Photoswitchable molecular assembly for controlled chloride transport across the lipid membranes
Chuantao Wang, Kai Ye, Zexin Yan, et al.
Science China Chemistry (2025)
Closed Access
Chuantao Wang, Kai Ye, Zexin Yan, et al.
Science China Chemistry (2025)
Closed Access
Prevalence of Cystic Fibrosis Carrier Status in Chronic Rhinosinusitis Without Nasal Polyp
Do‐Yeon Cho, Adam J. Skelton, Jessica W. Grayson, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Do‐Yeon Cho, Adam J. Skelton, Jessica W. Grayson, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Chloride channels and mast cell function: pioneering new frontiers in IBD therapy
Ahmed M. Aljameeli, Bader Alsuwayt, Deepak Bharati, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Ahmed M. Aljameeli, Bader Alsuwayt, Deepak Bharati, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Human Mesenchymal Stem Cell Therapy: Potential Advances for Reducing Cystic Fibrosis Infection and Organ Inflammation
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101602-101602
Closed Access
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101602-101602
Closed Access
CRISPR/Cas9 gene editing for treating gene and protein disorders
Chukwuebuka Emmanuel Umeyor, Preeya Negi, R. Agarwal, et al.
Elsevier eBooks (2025), pp. 519-553
Closed Access
Chukwuebuka Emmanuel Umeyor, Preeya Negi, R. Agarwal, et al.
Elsevier eBooks (2025), pp. 519-553
Closed Access
Ciliary Ion Channels in Polycystic Kidney Disease
Lubna A. Alshriem, Raghad Buqaileh, Qasim Alorjani, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 459-459
Open Access
Lubna A. Alshriem, Raghad Buqaileh, Qasim Alorjani, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 459-459
Open Access
Design and Validation of a Stability-Indicating RP-HPLC Technique for Quantifying Ivacaftor in Bulk and Commercial Formulations
Manisha D. Chate, Mushraff Ali Khan, Mohd Sayeed Shaikh, et al.
Current Pharmaceutical Analysis (2025)
Open Access
Manisha D. Chate, Mushraff Ali Khan, Mohd Sayeed Shaikh, et al.
Current Pharmaceutical Analysis (2025)
Open Access
The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic Fibrosis
Marta Solís García, Claudia Janeth Madrid-Carbajal, Adrián Peláez, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
Marta Solís García, Claudia Janeth Madrid-Carbajal, Adrián Peláez, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers
Fabiana Ciciriello, Marcel J. C. Bijvelds, Federico Alghisi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 632-632
Open Access | Times Cited: 19
Fabiana Ciciriello, Marcel J. C. Bijvelds, Federico Alghisi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 632-632
Open Access | Times Cited: 19
The Impact of Antimicrobial Resistance in Cystic Fibrosis
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 4
Role of epithelial sodium channel-related inflammation in human diseases
Yabin Chen, Xiao Yu, Zhiping Yan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Yabin Chen, Xiao Yu, Zhiping Yan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
mRNA biotherapeutics landscape for rare genetic disorders
Vivek Iyer, Praveen Reddy. P, Bhagyashree Kaduskar, et al.
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 3
Vivek Iyer, Praveen Reddy. P, Bhagyashree Kaduskar, et al.
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 3
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target
Marcus Mall, Jane C. Davies, Scott H. Donaldson, et al.
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 240001-240001
Open Access | Times Cited: 3
Marcus Mall, Jane C. Davies, Scott H. Donaldson, et al.
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 240001-240001
Open Access | Times Cited: 3
Regulation of Translation, Translocation, and Degradation of Proteins at the Membrane of the Endoplasmic Reticulum
Lea Daverkausen-Fischer, Margarethe Draga, Felicitas Pröls
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5576-5576
Open Access | Times Cited: 15
Lea Daverkausen-Fischer, Margarethe Draga, Felicitas Pröls
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5576-5576
Open Access | Times Cited: 15
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility
Giuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4244-4244
Open Access | Times Cited: 8
Giuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4244-4244
Open Access | Times Cited: 8
